World's first drug for treatment of Non-Cirrhotic NASH approved: Zydus Medical Dialogues Bureau6 March 2020 2:26 PM ISTSaroglitazar is uniquely poised with its dual PPAR alpha and gamma properties – reducing the comorbidities (dyslipidemia, hypertriglyceridemia,...
Patients with NASH have been enrolled in 3 phase III trials of Saroglitazar, says Zydus Cadila Medical Dialogues Bureau18 July 2019 9:17 AM IST"Patients with NASH have been enrolled in these trials across clinical sites in India and Mexico," Cadila Healthcare, the listed entity of the group,...